PLCG1 and T-cell non-Hodgkin lymphoma: Mutations in the TCR signaling components and PLCG1 have been observed in T-cell lymphoma patients, and these mutations are associated with poorer overall and progression-free survival rates based on several clinical studies [125,126,127].